Trachtenberg Eric 4
4 · Kala Pharmaceuticals, Inc. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
Trachtenberg Eric
General Counsel and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2023-03-14+432→ 432 totalExercise: $68.50Exp: 2032-01-03→ Common Stock (432 underlying)
Footnotes (2)
- [F1]On January 3, 2022, the Reporting Person was granted an option to purchase up to 1,620 shares of common stock of the Issuer. Specified portions of the options vest based on the level of achievement of specified performance metrics relating to financial, operational and scientific matters.
- [F2]On March 14, 2023, the Compensation Committee of the Issuer's Board of Directors determined that certain of the performance conditions were achieved at specific levels of achievement, resulting in vesting of the option as to 432 shares of common stock. The Compensation Committee has made no determination with respect to certain performance metrics, which could result in the further vesting of up to 324 shares of common stock underlying the option.